Long-lasting remission of severe Behçet's disease after the end of infliximab therapy

J Rheumatol. 2009 Apr;36(4):855. doi: 10.3899/jrheum.081063.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Anti-Inflammatory Agents / therapeutic use*
  • Antibodies, Monoclonal / therapeutic use*
  • Behcet Syndrome / drug therapy*
  • Behcet Syndrome / pathology
  • Behcet Syndrome / physiopathology*
  • Humans
  • Infliximab
  • Male
  • Remission Induction
  • Young Adult

Substances

  • Anti-Inflammatory Agents
  • Antibodies, Monoclonal
  • Infliximab